Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/22475
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNolla Solé, Joan Miquelcat
dc.contributor.authorFiter, Jordicat
dc.contributor.authorGómez Vaquero, Carmencat
dc.contributor.authorAlegre-Sancho, Juan Josécat
dc.contributor.authorValverde García, Josécat
dc.contributor.authorRoig Escofet, D. (Daniel)cat
dc.date.accessioned2012-03-05T12:52:34Z-
dc.date.available2012-03-05T12:52:34Z-
dc.date.issued2001-
dc.identifier.issn0003-4967-
dc.identifier.urihttp://hdl.handle.net/2445/22475-
dc.description.abstractCriteria to decide which patients with rheumatoid arthritis (RA) should be examined by dual energy x ray absorptiometry (DXA) are currently not available. The rheumatologists from Amsterdam have proposed preliminary criteria based on clinical risk factors (age, disease activity, and functional status). These criteria are preliminary and not widely accepted but might be helpful in practice. The value of the proposal in a group of Spanish postmenopausal women with RA is analysed. METHODS DXA (lumbar spine and femoral neck) was performed in 128 patients recruited from a clinical setting, and the proposed criteria were applied. T and Z scores were established for a Spanish reference population. RESULTS The mean (SD) age of the patients was 61.3 (10.7) and mean duration of the postmenopausal period 14.5 (10.1) years. Mean duration of RA was 13.7 (7.7) years. Mean C reactive protein was 22 (21) mg/l; mean erythrocyte sedimentation rate 26 (18) mm/1st h; and mean Health Assessment Questionnaire score 1.25 (0.79). Ninety (70%) patients fulfilled the proposed criteria. Their sensitivity for the diagnosis of osteoporosis (T score ¿¿2.5 SD) was 86% and their specificity, 43%. Positive predictive value was 54% and negative predictive value, 79%. CONCLUSIONS The proposed criteria seem a good screening method for the selection of those patients with RA whose bone mineral density should be assessed as the sensitivity and negative predictive value are acceptable.eng
dc.format.extent3 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengeng
dc.publisherBMJ Group-
dc.relation.isformatofReproducció digital del document publicat a: http://dx.doi.org/10.1136/ard.60.8.799-
dc.relation.ispartofAnnals of the Rheumatic Diseases, 2001, vol. 60, núm. 8, p. 799-801-
dc.relation.urihttp://dx.doi.org/10.1136/ard.60.8.799-
dc.rights(c) BMJ Publishing Group Ltd, 2001-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationDensitometria òssiacat
dc.subject.classificationArtritis reumatoidecat
dc.subject.classificationMenopausacat
dc.subject.classificationDiagnòsticcat
dc.subject.otherBone densitometryeng
dc.subject.otherRheumatoid arthritiseng
dc.subject.otherMenopauseeng
dc.subject.otherDiagnosiseng
dc.titleValue of clinical factors in selecting postmenopausal women with rheumatoid arthritis for bone densitometry.eng
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec535344-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid11454646-
Appears in Collections:Articles publicats en revistes (Ciències Clíniques)

Files in This Item:
File Description SizeFormat 
535344.pdf101.04 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.